<DOC>
	<DOCNO>NCT00475683</DOCNO>
	<brief_summary>Mucositis consist inflammation mucosal membrane prominent cause patient discomfort cancer therapy . In child receive chemotherapy , incidence oral mucositis report 40 % -70 % . Curcumin , commonly-used spice India Southeast Asia , show animal model prevent chemotherapy radiotherapy induce mucositis . We hypothesize curcumin may prevent oral mucosal injury reduce severity oral mucositis child receive chemotherapy . Thus , aim study determine whether child undergo doxorubicin-containing chemotherapy , supplementation curcumin , compare placebo , decrease oral mucositis objective ( mucositis scale ) subjective ( pain scale ) measurement . Effective prevention reduction mucosal injury may significantly improve care provide child undergo therapy cancer .</brief_summary>
	<brief_title>Curcumin Prevention Oral Mucositis Children Chemotherapy</brief_title>
	<detailed_description>Children old 5 year age diagnose cancer treat Pediatric Hematology/Oncology unit , Hadassah Medical Center eligible study . The study design cross-over study , wherein patient serf control , thus include child schedule receive least two identical curse doxorubicin-containing chemotherapy dose doxorubicin least 60mg/m2 per course . The patient assign randomly receive curcumin placebo 1st course , regimen administer 2nd course . Curcumin give fluid extract ( 1:1 ) dose 10 drop , three time day . Adolescents young adult receive adult recommend dose , i.e . 30 drop , three time day . Placebo give dose . The patient teach rinse mouth medicine spit . The therapy give day prior first day cycle two week . A diary keep family record give dose . Possible side effect associate study drug , vomit , nausea , rash , etc. , record . No adjunctive topical treatment use study . Adherence assess subject report well review return medication every cycle collect objective assessment site visit . Given intent-to-treat analysis , participant include irrespective much study medication taken.The measurement study outcome , i.e . OMAS score , WHO mucositis scale visual analogue pain scale do day 1,7,10,14,21 Â± 1 chemotherapy cycle . The following data record cycle : duration neutropenia , need length hospitalization , use dosage opioid analgesia , need total potential nutrition , blood culture positive infection mucositis related complication .</detailed_description>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>1 . Children old 5 year age , adolescent young adult diagnose cancer treat Pediatric Hematology/Oncology unit , Hadassah Medical Center , 2 . A crossover study design plan wherein patient serf control , thus include child schedule receive least two identical curse doxorubicincontaining chemotherapy dose doxorubicin least 60mg/m2 per course , 3 . Patient's/ parent 's informed consent . 1 . Patients treat antiplatelet therapy anticoagulation , 2 . Patients biliary tract obstruction , 3 . Patients preexist oral disease , active oral infection , trauma oral mucosa oral ulceration prior chemotherapy , 4 . Patients receive head neck radiation , 5 . Developmentally unable comply curcumin mouth wash judge parent investigator .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Doxorubicin</keyword>
	<keyword>Mucositis</keyword>
	<keyword>Prevention</keyword>
	<keyword>Curcumin</keyword>
</DOC>